Cargando…

The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway

BACKGROUND: Antimicrobial Stewardship is a coordinated effort to improve and measure the appropriate use of antimicrobials. Antibiotic resistance is an emerging world health problem and unnecessary prescribing of broad-spectrum antibiotics is a major contributor to this. Skin and soft-tissue infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalziel, Andrew, Smyth, Daniel, Ghaly, Ahmed, MacLaggan, Timothy, Stoica, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107068/
http://dx.doi.org/10.1093/ofid/ofx163.1322
_version_ 1783512738068168704
author Dalziel, Andrew
Smyth, Daniel
Ghaly, Ahmed
MacLaggan, Timothy
Stoica, George
author_facet Dalziel, Andrew
Smyth, Daniel
Ghaly, Ahmed
MacLaggan, Timothy
Stoica, George
author_sort Dalziel, Andrew
collection PubMed
description BACKGROUND: Antimicrobial Stewardship is a coordinated effort to improve and measure the appropriate use of antimicrobials. Antibiotic resistance is an emerging world health problem and unnecessary prescribing of broad-spectrum antibiotics is a major contributor to this. Skin and soft-tissue infections are a common reason to receive a prescription for antibiotics. Currently there exists a trend for using broad-spectrum intravenous antibiotics for moderate to severe infections when more narrow-spectrum options would be adequate. This study aimed to characterize the choice of antibiotic being prescribed for the management of outpatient cellulitis requiring intravenous antibiotics and evaluate the success of a clinical order set outlining optimal therapy. METHODS: This study was a retrospective chart review looking at antibiotic prescribing through the Emergency Department at The Moncton Hospital, in Moncton, New Brunswick. Charts were reviewed before and after the introduction of a clinical order set outlining optimal antibiotic therapy. The goal was to review charts from the pre- and post-intervention group and compare antibiotic usage, treatment failure rates, and adverse events. RESULTS: Of the 54 patients receiving IV antibiotics in the pre-intervention group, 3 received cefazolin, 50 received ceftriaxone, while 1 received levofloxacin. The median duration of IV therapy was four days. After the introduction of the clinical order set there was an absolute increase of 53.8% (n = 35) in the use of cefazolin and absolute decrease of 53.7% (n = 23) in the use of ceftriaxone in the post-intervention group of 59 patients. Both results were statistically significant (P < 0.001). The median duration of IV therapy in this group was 3.5 days. In eligible patients, the clinical order set was utilized 61.1% of the time. There was no significant difference in rates of treatment failure or adverse events between cefazolin and ceftriaxone. CONCLUSION: The introduction of a clinical order set outlining the preferential use of once-daily cefazolin plus probenecid for the treatment of outpatient cellulitis lead to a statistically significant increase use of cefazolin, and decrease use of ceftriaxone, thus demonstrating a positive stewardship effect at a local level. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-7107068
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71070682020-04-02 The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway Dalziel, Andrew Smyth, Daniel Ghaly, Ahmed MacLaggan, Timothy Stoica, George Open Forum Infect Dis Abstracts BACKGROUND: Antimicrobial Stewardship is a coordinated effort to improve and measure the appropriate use of antimicrobials. Antibiotic resistance is an emerging world health problem and unnecessary prescribing of broad-spectrum antibiotics is a major contributor to this. Skin and soft-tissue infections are a common reason to receive a prescription for antibiotics. Currently there exists a trend for using broad-spectrum intravenous antibiotics for moderate to severe infections when more narrow-spectrum options would be adequate. This study aimed to characterize the choice of antibiotic being prescribed for the management of outpatient cellulitis requiring intravenous antibiotics and evaluate the success of a clinical order set outlining optimal therapy. METHODS: This study was a retrospective chart review looking at antibiotic prescribing through the Emergency Department at The Moncton Hospital, in Moncton, New Brunswick. Charts were reviewed before and after the introduction of a clinical order set outlining optimal antibiotic therapy. The goal was to review charts from the pre- and post-intervention group and compare antibiotic usage, treatment failure rates, and adverse events. RESULTS: Of the 54 patients receiving IV antibiotics in the pre-intervention group, 3 received cefazolin, 50 received ceftriaxone, while 1 received levofloxacin. The median duration of IV therapy was four days. After the introduction of the clinical order set there was an absolute increase of 53.8% (n = 35) in the use of cefazolin and absolute decrease of 53.7% (n = 23) in the use of ceftriaxone in the post-intervention group of 59 patients. Both results were statistically significant (P < 0.001). The median duration of IV therapy in this group was 3.5 days. In eligible patients, the clinical order set was utilized 61.1% of the time. There was no significant difference in rates of treatment failure or adverse events between cefazolin and ceftriaxone. CONCLUSION: The introduction of a clinical order set outlining the preferential use of once-daily cefazolin plus probenecid for the treatment of outpatient cellulitis lead to a statistically significant increase use of cefazolin, and decrease use of ceftriaxone, thus demonstrating a positive stewardship effect at a local level. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC7107068/ http://dx.doi.org/10.1093/ofid/ofx163.1322 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Dalziel, Andrew
Smyth, Daniel
Ghaly, Ahmed
MacLaggan, Timothy
Stoica, George
The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway
title The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway
title_full The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway
title_fullStr The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway
title_full_unstemmed The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway
title_short The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway
title_sort management of outpatient cellulitis at the moncton hospital before and after the initiation of a clinical treatment pathway
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107068/
http://dx.doi.org/10.1093/ofid/ofx163.1322
work_keys_str_mv AT dalzielandrew themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT smythdaniel themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT ghalyahmed themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT maclaggantimothy themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT stoicageorge themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT dalzielandrew managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT smythdaniel managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT ghalyahmed managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT maclaggantimothy managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway
AT stoicageorge managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway